Daniel B Roth MD
Retinal Disease, Uveitis
Clinical Professor of Ophthalmology at Rutgers Robert Wood Johnson Medical School
Join to View Full Profile
525 NJ-70 WSuite 600Lakewood, NJ 08701
Phone+1 732-363-2396
Fax+1 732-363-0403
Dr. Roth is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Daniel Roth, MD, is an ophthalmologist located in Lakewood, NJ, specializing in retinal disease and uveitis. He completed his medical education at Yale School of Medicine in 1994 and pursued further training in ophthalmology at the University of Miami/Jackson Health System/Bascom Palmer Eye Institute. Dr. Roth is a partner at Associated Retinal Consultants since 2000 and is experienced with conditions such as retinopathy of anemia, macular edema, retina surgery, vitreoretinal disease, and pediatric retinal disease. His research contributions include several publications on topics like diabetic macular edema and intravitreal injection-related complications. He has participated in clinical trials such as the ORBIT study and has received recognition from various professional organizations, including Castle Connolly's Top Doctors and the Retina Society.
Education & Training
Cleveland Clinic FoundationFellowship, Surgical Retina and Vitreous, 1998 - 2000
University of Miami/Jackson Health System/Bascom Palmer Eye InstituteResidency, Ophthalmology, 1995 - 1998
University of Tennessee College of Medicine (Memphis)Internship, Internal Medicine, 1994 - 1995
Yale School of MedicineClass of 1994
Certifications & Licensure
NJ State Medical License 2000 - 2027
OH State Medical License 1998 - 2002
FL State Medical License 1996 - 2000
American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Best Doctors in America Best Doctors
- Member Retina Society
- Member Macula Society
Clinical Trials
- Antenatal Vitamin D3 Supplementation in Bangladesh: Randomized Controlled Trial Start of enrollment: 2010 Aug 01
- Observational Study to Evaluate and Compare the Rate and Extent of Inflammation After a Single Intravitreal Injection of Ranibizumab vs. a Single Intravitreal Injection of Aflibercept in Treatment Naive and Treatment Experienced Patients. Start of enrollment: 2013 Dec 01
- Ocriplasmin Research to Better Inform Treatment (ORBIT) Start of enrollment: 2014 May 01
Publications & Presentations
PubMed
- 6 citationsThe 0.19-mg Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema: Intraocular Pressure-Related Effects over 36 Months.Daniel B Roth, David Eichenbaum, Deepika Malik, Nathan M Radcliffe, Antonio Cutino
Ophthalmology. Retina. 2024-01-01 - Corrigendum to "The 0.19-mg Fluocinolone Acetonide Intravitreal Implant Reduces Treatment Burden in Diabetic Macular Edema" [Am J Ophthalmol 2023;248;16-23].Pauline T Merrill, Nancy Holekamp, Daniel Roth, Jonathan Kasper, Ruben Grigorian
American Journal of Ophthalmology. 2023-08-01 - 7 citationsThe 0.19-mg Fluocinolone Acetonide Intravitreal Implant Reduces Treatment Burden in Diabetic Macular Edema.Pauline T Merrill, Nancy Holekamp, Daniel Roth, Jonathan Kasper, Ruben Grigorian
American Journal of Ophthalmology. 2023-04-01
Press Mentions
Prism Vision Group’s Physicians Reviewed and Approved as NJ Top Docs for 2021June 3rd, 2021
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
